| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa3baa0c50ebdc467e86eeb04c1934d5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-233 |
| filingDate |
2017-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f881a1585ed26dfb812cc84ed4465ae7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e556e18f26a121b2bd0a58b8c3ec810
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48ae2bf6afc1b2026f365e38a0790a91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_501de016f6a511409f8b9e9cd2bc2be7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_250c20991fe17f2526eea26af29a80f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cd0016a7b6083cd184b20ce80ba32e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_480aa8cbccb6b23e623d643fb8ede90d |
| publicationDate |
2020-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020024235-A1 |
| titleOfInvention |
Crystal form and salt form of and preparation method for tyrosine kinase inhibitor |
| abstract |
Disclosed are a crystal form and a salt form of and a preparation method for a tyrosine kinase inhibitor. |
| priorityDate |
2016-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |